Holen Sie sich die Stockscreener-App
34.59
0.37%
-0.13
Handel nachbörslich:
35.00
0.41
+1.19%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$34.72
Offen:
$34.94
24-Stunden-Volumen:
865.98K
Relative Volume:
0.93
Marktkapitalisierung:
$1.73B
Einnahmen:
$203.27M
Nettoeinkommen (Verlust:
$-4.66M
KGV:
-345.90
EPS:
-0.1
Netto-Cashflow:
$3.47M
1W Leistung:
+8.53%
1M Leistung:
+5.46%
6M Leistung:
+158.71%
1J Leistung:
+92.92%
1-Tages-Spanne:
$34.43
$35.50
1-Wochen-Bereich:
$31.50
$35.50
52-Wochen-Spanne:
$9.215
$35.50
Axogen Inc Stock (AXGN) Company Profile
Firmenname
Axogen Inc
Sektor
Branche
Telefon
(386) 462-6817
Adresse
13631 PROGRESS BLVD., ALACHUA, FL
Vergleichen Sie AXGN mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
AXGN
Axogen Inc
|
34.59 | 1.74B | 203.27M | -4.66M | 3.47M | -0.10 |
|
ABT
Abbott Laboratories
|
108.27 | 189.14B | 44.33B | 6.48B | 6.92B | 3.7033 |
|
BSX
Boston Scientific Corp
|
93.61 | 138.74B | 19.35B | 2.78B | 3.82B | 1.8696 |
|
SYK
Stryker Corp
|
354.57 | 136.52B | 24.38B | 2.94B | 4.07B | 7.6159 |
|
MDT
Medtronic Plc
|
100.69 | 129.06B | 34.76B | 4.79B | 5.21B | 3.7017 |
|
EW
Edwards Lifesciences Corp
|
83.60 | 48.90B | 5.88B | 1.34B | 799.60M | 2.3489 |
Axogen Inc Stock (AXGN) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-12-01 | Eingeleitet | Mizuho | Outperform |
| 2025-03-17 | Eingeleitet | Lake Street | Buy |
| 2024-07-01 | Eingeleitet | Raymond James | Outperform |
| 2022-11-11 | Fortgesetzt | Jefferies | Buy |
| 2022-05-09 | Hochstufung | Canaccord Genuity | Hold → Buy |
| 2022-03-11 | Fortgesetzt | Cantor Fitzgerald | Overweight |
| 2020-10-23 | Eingeleitet | Guggenheim | Buy |
| 2020-06-16 | Fortgesetzt | Cantor Fitzgerald | Overweight |
| 2020-05-07 | Herabstufung | Canaccord Genuity | Buy → Hold |
| 2020-04-02 | Herabstufung | BTIG Research | Buy → Neutral |
| 2019-08-07 | Herabstufung | William Blair | Outperform → Mkt Perform |
| 2019-07-12 | Eingeleitet | Canaccord Genuity | Buy |
| 2018-03-02 | Bestätigt | Lake Street | Buy |
| 2018-01-05 | Fortgesetzt | Cantor Fitzgerald | Overweight |
| 2017-11-30 | Eingeleitet | Jefferies | Buy |
| 2017-11-21 | Bestätigt | Lake Street | Buy |
| 2017-07-31 | Eingeleitet | Leerink Partners | Outperform |
| 2017-06-30 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2017-03-06 | Eingeleitet | ROTH Capital | Buy |
| 2016-11-22 | Hochstufung | Lake Street | Hold → Buy |
| 2016-11-07 | Bestätigt | Wedbush | Outperform |
| 2016-11-03 | Herabstufung | Lake Street | Buy → Hold |
| 2016-08-04 | Bestätigt | Wedbush | Outperform |
| 2014-05-14 | Eingeleitet | Dawson James | Buy |
| 2013-10-31 | Bestätigt | Ladenburg Thalmann | Buy |
Alle ansehen
Axogen Inc Aktie (AXGN) Neueste Nachrichten
Analysts Offer Insights on Healthcare Companies: AxoGen (AXGN) and Viking Therapeutics (VKTX) - The Globe and Mail
Axogen stock hits 52-week high at 34.79 USD By Investing.com - Investing.com Nigeria
Aug Levels: Is Axogen Inc a play on infrastructure spendingWeekly Trading Summary & Expert Approved Trade Ideas - baoquankhu1.vn
AxoGen (NASDAQ:AXGN) Sets New 52-Week High Following Analyst Upgrade - MarketBeat
Axogen Inc (AXGN) Trading 4.65% Higher on Jan 26 - GuruFocus
Axogen stock hits 52-week high at 34.79 USD - Investing.com
Income Plays: Is DESP on track to beat earningsRate Hike & Weekly High Conviction Trade Ideas - baoquankhu1.vn
Axogen, Inc. (NASDAQ:AXGN) On The Verge Of Breaking Even - 富途牛牛
A Look At Axogen (AXGN) Valuation After Its Upsized US$124 Million Equity Offering - Yahoo Finance
Axogen Upsized Equity Raise Shifts Debt Profile And Valuation Focus - Sahm
Is Axogen Inc.’s growth already priced inJuly 2025 Technicals & Fast Entry and Exit Trade Plans - mfd.ru
AxoGen (NASDAQ:AXGN) Rating Increased to Strong-Buy at Wall Street Zen - MarketBeat
Axogen (AXGN) Is Up 5.8% After Upsized Equity Raise and Debt PaydownWhat's Changed - Yahoo Finance
AxoGen Announces Equity Offering to Repay Term Loan - TipRanks
Axogen Signs Underwriting Agreement With Wells Fargo Securities and Mizuho Securities USA - TradingView
Axogen (AXGN) prices stock offering and targets $69.7M term loan payoff - Stock Titan
Analysts Offer Insights on Healthcare Companies: Rani Therapeutics Holdings (RANI), Ardelyx (ARDX) and AxoGen (AXGN) - The Globe and Mail
AxoGen (NASDAQ:AXGN) Shares Gap DownTime to Sell? - MarketBeat
Axogen plans $85 million stock offering to repay debt By Investing.com - Investing.com Australia
Axogen stock dips after pricing $124M offering - MSN
Axogen (AXGN) Increases Stock Offering to $124 Million - GuruFocus
Axogen (AXGN) Shares Decline After Upsized Public Offering - GuruFocus
Axogen prices upsized public offering of common stock at $31 per share - Investing.com Nigeria
Axogen Announces Pricing of Upsized $124 Million Public Offering of Common Stock - The Manila Times
Surgical nerve repair company Axogen prices $124M stock sale to pay off term loan - Stock Titan
Axogen announces proposed $85M public stock offering; shares down - MSN
Axogen stock falls after $85 million share offering announcement By Investing.com - Investing.com Nigeria
Axogen stock falls after $85 million share offering announcement - Investing.com
Axogen plans $85 million stock offering to repay debt - Investing.com
Surgical device maker Axogen falls on stock offering plans - TradingView — Track All Markets
Axogen Inc Files For Mixed Shelf Offering Size Not Disclosed - TradingView
Axogen, Inc. Plans $85 Million Public Offering of Common Stock - Quiver Quantitative
Axogen Announces Proposed Public Offering of Common Stock - GlobeNewswire
Axogen plans $85M stock sale to repay loan and fund operations - Stock Titan
Did Strong 2025 Revenue Guidance Just Shift Axogen's (AXGN) Nerve Repair Investment Narrative? - simplywall.st
Understanding Momentum Shifts in (AXGN) - Stock Traders Daily
Assessing Axogen (AXGN) Valuation After FDA Approval And Higher 2025 Revenue Guidance - Sahm
AxoGen, Inc. (AXGN) Stock Analysis: A Promising 18.51% Potential Upside in the Healthcare Sector - DirectorsTalk Interviews
AxoGen Touts Post-BLA Growth Plan, 75%+ Gross Margin Outlook at J.P. Morgan Healthcare Conference - MarketBeat
Axogen CEO Axed 25,000 Shares From His Direct Holdings - The Globe and Mail
Stock Analysis: How Axogen Inc stock compares to growth peersGap Up & Low Drawdown Trading Techniques - Bộ Nội Vụ
AxoGen stock gains as Canaccord reiterates Buy rating on strong results By Investing.com - Investing.com South Africa
AxoGen stock gains as Canaccord reiterates Buy rating on strong results - Investing.com Canada
Primoris Wealth Advisors LLC Boosts Holdings in AxoGen, Inc. $AXGN - MarketBeat
Axogen Announces Strong Preliminary Fourth-Quarter 2025 Revenue Growth - The Globe and Mail
Why Axogen (AXGN) Is Up 5.5% After Strong Preliminary 2025 Revenue Guidance And What's Next - simplywall.st
Finanzdaten der Axogen Inc-Aktie (AXGN)
Umsatz
Nettogewinn
Free Cashflow
ENV
2.36%
0.96%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):